Oklahoma Shared Clinical and Translational Resources
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-11406205 · Data updated 2026-11-12
A statewide program that speeds up health research by connecting clinicians, researchers, and data/resources to improve health in Oklahoma.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | September 1, 2013 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $3,999,999 |
| NIH project number | 5U54GM104938-14 |
| Project ID | NIH-11406205 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients in Oklahoma with cancer, diabetes, cardiovascular disease, arthritis, autoimmune conditions, or related health concerns who participate in CTR activities or benefit from improved care pathways.
✕Less likely to help
Patients not directly involved in CTR activities or whose health outcomes are not immediately influenced by the program’s translational activities.
What this research studies
The Oklahoma Shared Clinical and Translational Resources (OSCTR) brings together hospitals, universities, and community partners to accelerate clinical research that addresses Oklahoma’s top health concerns. It provides access to a CAP-certified biorepository and advanced clinical data resources to support investigators across more than 30 partners. By fostering collaborations and building CTR careers, OSCTR aims to generate practical findings that can improve outcomes for conditions like cancer, diabetes, cardiovascular disease, arthritis, and autoimmune disorders. The program operates within the Oklahoma IDA state context, leveraging local patient populations and health system networks to translate discoveries into real-world care.
Why it matters
Potential benefit: If successful, it could hasten the development and implementation of improved diagnoses, treatments, and preventive strategies for major health issues affecting Oklahomans.
How similar studies have gone: Previous programs integrating clinical and translational resources have shown that robust biorepositories and data access can accelerate study timelines and improve patient-centered outcomes.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: James, Judith a — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: James, Judith a
Related research
Other NIH-funded projects on the same topics.
-
Primary care research network in Oklahoma to boost rural patient trials
A nationwide NIH-supported effort to strengthen Oklahoma’s primary care research network so doctors can run big clinical trials and real‑world studies in rural communities.
-
N-myristoylation and DNA damage response in Alzheimer’s disease
A study to understand how a protein modification called myristoylation affects the DNA damage response in people who have Alzheimer’s-related conditions.
-
Genetically engineered mouse model to study and treat high-risk pediatric rhabdomyosarcoma
A research project aims to create mouse models that mimic high-risk pediatric rhabdomyosarcoma and test therapies that target the NOTCH1 pathway to slow or stop tumor growth.
-
Understanding how bone cancer cells rely on certain pathways to grow in childhood osteosarcoma
This grant studies how specific cancer-related pathways in bone-forming cells drive osteosarcoma in children, with the aim of finding better treatments.
-
Vascular signals from brain blood vessels influence immune-suppressing cells in glioblastoma
This grant explores how blood vessel cells in glioblastoma shape immune cells to help the tumor grow, with the aim of making immunotherapies work better for patients.
-
TFEB as a key switch to keep muscles healthy as we age
A study in aging adults and aging muscle tissues looks at whether boosting TFEB can improve how muscles maintain themselves and recover after disuse.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.